Stefan Maksimović: Our first paper about TKIs and ccRCC in bone and lung!

Stefan Maksimović shared a post by Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, on X, adding:

“Finally! Here we go: our first paper about TKIs and ccRCC in bone and lung! Honored to lead this effort and many more to come! Nothing without wonderful mentors Eleonora Dondossola and Matt Campbell and great team.

Quoting Mohammad Jad Moussa’s post:

“Our Latest From Bone Mets Lab and Team, now in CRC AACR – Dr. Eleonora Dondossola and Dr. Matt Campbell of GU Oncology.

Lead S. Maksimović TKI activity and efficacy (cabo, lenva, axi) in orthotopic mouse models of bone-metastatic ccRCC, studying

• survival,
• TKI rechallenge and
• MoA/effect on bone stromal niche!”

Antiangiogenic tyrosine kinase inhibitors have differential efficacy in clear cell renal cell carcinoma in bone

Authors: Stefan Maksimovic, Nina C Boscolo, Ludovica La Posta, Sergio Barrios, Mohammad Jad Moussa, Pedro I Pesquera, Wenjiao Li, Jianfeng Chen, Javier A Gomez, Akshay Basi, Jared K Burks, Christopher Alvarez-Breckenridge, Jianjun Gao, Matthew T Campbell, Eleonora Dondossola

Source: Stefan Maksimović/X and Mohammad Jad Moussa/X

Stefan Maksimović is a Postdoctoral Researcher in GU Medical Oncology at MD Anderson Cancer Center. He previously held a postdoctoral position at the University of Colorado Anschutz Medical Campus. His interests include basic oncology research and oncology practice in the U.S.